CLINICAL_TRIALS
research
· 2010-03-03
Clinical Trial Update: Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer [Phase 2]
Summary
Phase 2 clinical trial update evaluating the combination of docetaxel and oxaliplatin for pancreatic cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Ulm | Conditions: Pancreas Neoplasms | Phase 2 | Status: UNKNOWN